Saturday, October 4, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Mergers & Acquisitions

Iteris Stock: A Chapter Closes Following Acquisition

Robert Sasse by Robert Sasse
October 4, 2025
in Mergers & Acquisitions, Nasdaq, Tech & Software
0
Iteris Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

For market participants researching Iteris stock, one crucial reality must be understood: the company’s public trading status concluded over a year ago. Iteris was officially delisted from the NASDAQ on November 1, 2024, following its acquisition by the Italian firm Almaviva S.p.A.

The Final Transaction

The path to delisting was set in motion on August 9, 2024, when Almaviva publicly revealed its agreement to purchase Iteris. This all-cash transaction, valued at approximately $335 million, provided shareholders with a substantial premium. They received $7.20 for each share they held, representing a significant 68% increase over the stock’s closing price from the day before the acquisition was announced.

Following successful shareholder approval on October 23, 2024, the deal was finalized. Since the delisting on November 1, 2024, Iteris shares have no longer been available for public trading on the NASDAQ or any other exchange.

Should investors sell immediately? Or is it worth buying Iteris?

Navigating Outdated Financial Information

A notable concern for investors is the persistence of obsolete data across numerous financial platforms. These sites continue to display outdated price charts and, in some cases, even future projections for the delisted security. As recently as October 3, 2025, MarketBeat issued a specific warning regarding potentially delisted stocks. For clarity, Investing.com confirms that Iteris has been operating as a wholly-owned subsidiary of Almaviva since November 2024.

Despite the change in corporate ownership, Iteris continues its business operations under the established leadership of CEO Joe Bergera. The company remains dedicated to its ClearMobility® platform, now benefiting from the international backing and resources of its new parent company.

Implications for Former Shareholders

For traders and investors, this development marks a definitive conclusion. There will be no further quarterly earnings reports, no new analyst coverage, and no share price fluctuations to track. Anyone interested in the future trajectory of the company’s underlying business must now follow the corporate communications and disclosures from Almaviva S.p.A. The era of the Iteris stock has reached its end.

Ad

Iteris Stock: Buy or Sell?! New Iteris Analysis from October 4 delivers the answer:

The latest Iteris figures speak for themselves: Urgent action needed for Iteris investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 4.

Iteris: Buy or sell? Read more here...

Tags: Iteris
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Micron Stock
Analysis

Micron Shares Surge as AI Demand Fuels Record Performance

October 4, 2025
Proterra Incorporation Registered (A) Stock
Automotive & E-Mobility

Proterra Reaches $29 Million Settlement Amid Bankruptcy Proceedings

October 4, 2025
Lyra Therapeutics Inc Stock
Nasdaq

Biotech Firm Lyra Therapeutics Faces Critical Nasdaq Deadline

October 4, 2025
Next Post
Tucows Stock

Tucows Shares Face Mounting Pressure as Downtrend Accelerates

iShares MSCI India ETF Stock

India's Economic Momentum Fuels Optimism for iShares MSCI India ETF

Genie Energy Stock

Genie Energy Shares Signal Potential Reversal After Prolonged Downturn

Recommended

Ocugen Stock

Ocugen’s Gene Therapy Strategy Aligns with Projected Boom in Retinal Biologics Market

1 month ago
Alphabet Stock

Regulatory Storm Gathers Over Alphabet’s European Operations

3 days ago
Finance_ Charts for stock trading

Whales in the Market Analyzing Options Activities for SoundHound AI

2 years ago

BTIG Analyst Initiates Coverage on flyExclusive with Buy Rating and 9 Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Iovance Stock: Assessing the Rally’s Staying Power

Biotech Stock Soars on Regulatory Breakthrough

Enveric Biosciences Stock: Conflicting Signals Follow Key Milestone

Biotech Firm Lyra Therapeutics Faces Critical Nasdaq Deadline

Solo Brands Faces Mounting Crisis as Quarterly Results Disappoint

Genprex Shares Plunge Amid Heavy Selling Pressure

Trending

Micron Stock
Analysis

Micron Shares Surge as AI Demand Fuels Record Performance

by Felix Baarz
October 4, 2025
0

Investors are showing renewed confidence in memory chip leader Micron Technology following the company's outstanding financial results...

Realty Income Stock

Insider Selling Raises Questions About Realty Income’s Outlook

October 4, 2025
Proterra Incorporation Registered (A) Stock

Proterra Reaches $29 Million Settlement Amid Bankruptcy Proceedings

October 4, 2025
Iovance Biotherapeutics Stock

Iovance Stock: Assessing the Rally’s Staying Power

October 4, 2025
Applied Therapeutics Stock

Biotech Stock Soars on Regulatory Breakthrough

October 4, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Micron Shares Surge as AI Demand Fuels Record Performance
  • Insider Selling Raises Questions About Realty Income’s Outlook
  • Proterra Reaches $29 Million Settlement Amid Bankruptcy Proceedings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com